Listeria monocytogenes and its products as agents for cancer immunotherapy

Patrick Guirnalda1, Laurence Wood, Yvonne Paterson

  • 1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Advances in Immunology
|January 17, 2012
PubMed

Insights

Listeria monocytogenes are being developed as cancer immunotherapeutics. These bacteria are engineered as vectors to deliver tumor antigens and angiogenic molecules, stimulating an immune response against tumors.

Area of Science:

  • Immunology
  • Oncology
  • Microbiology

Background:

  • Listeria monocytogenes possesses unique properties making it a candidate for cancer immunotherapy.
  • Understanding its virulence factors is key to developing effective cancer vaccines.

Purpose of the Study:

  • To review the application of Listeria monocytogenes and its virulence factors in cancer immunotherapy.
  • To explore the use of Listeria as a vaccine vector for tumor immunotherapy.

Main Methods:

  • Engineering Listeria monocytogenes as a vector for delivering tumor antigens and DNA plasmids.
  • Utilizing Listeria's tumor-homing capabilities for targeted delivery.
  • Employing Listeria to deliver angiogenic molecules to disrupt tumor vasculature.

Main Results:

  • Listeria monocytogenes can be engineered to target antigen-presenting cells.
  • Harnessing tumor-homing properties enhances targeted cancer therapy.
  • Listeria-mediated delivery of angiogenic molecules can induce anti-tumor immune responses.

Conclusions:

  • Listeria monocytogenes shows promise as a versatile platform for cancer immunotherapy.
  • Further development of Listeria-based vaccines could lead to novel cancer treatments.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...